Work

Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancer.

Year: 1984

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: J Mortimer, R B Livingston, I J Hardesty, C W Groppe, J D Purvis, M Gupta, N Flournoy

Institution: University of Washington

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2396713847

FWCI: 0.537

Cites:

Cited by: 3

Related to: 10